Abstract
B7 homolog 1 (B7-H1) is a recently discovered immunoresistance protein that is regulated posttranscriptionally after PTEN loss in malignant glioma, a deadly form of brain tumor. Here, the impact of γ-interferon-mediated activation of B7-H1 was investigated in glioblastoma patients with PTEN loss. Lymphocytes and T cells were selected for apoptosis assays after 1 : 1 coculture with autologous glioma cells. Gamma interferon treatment of PTEN-deficient tumors resulted in superinduction of B7-H1 protein that correlated with increased T-cell apoptosis, an effect dependent upon activation of the PI3-kinase pathway. The combination of PTEN loss and γ-interferon exposure in glioblastoma patients results in an exceptionally immunoresistant phenotype that may negate adaptive immunity through induction of T-cell apoptosis.
Original language | English (US) |
---|---|
Pages (from-to) | 1597-1602 |
Number of pages | 6 |
Journal | NeuroReport |
Volume | 20 |
Issue number | 18 |
DOIs | |
State | Published - Dec 2009 |
Externally published | Yes |
Keywords
- B7 homolog 1
- Glioma
- Immune evasion
- Immunoresistance
- Interferon gamma
- Programmed death ligand-1
ASJC Scopus subject areas
- General Neuroscience